25114826|t|Immunosuppressant-associated neurotoxicity responding to olanzapine.
25114826|a|Immunosuppressants, particularly tacrolimus, can induce neurotoxicity in solid organ transplantation cases. A lower clinical threshold to switch from tacrolimus to another immunosuppressant agent has been a common approach to reverse this neurotoxicity. However, immunosuppressant switch may place the graft at risk, and, in some cases, continuation of the same treatment protocol may be necessary. We report a case of immunosuppressant-associated neurotoxicity with prominent neuropsychiatric manifestation and describe psychiatric intervention with olanzapine that led to clinical improvement while continuing tacrolimus maintenance. 
25114826	29	42	neurotoxicity	Disease	MESH:D020258
25114826	57	67	olanzapine	Chemical	MESH:D000077152
25114826	102	112	tacrolimus	Chemical	MESH:D016559
25114826	125	138	neurotoxicity	Disease	MESH:D020258
25114826	219	229	tacrolimus	Chemical	MESH:D016559
25114826	308	321	neurotoxicity	Disease	MESH:D020258
25114826	517	530	neurotoxicity	Disease	MESH:D020258
25114826	546	576	neuropsychiatric manifestation	Disease	MESH:D012877
25114826	590	601	psychiatric	Disease	MESH:D001523
25114826	620	630	olanzapine	Chemical	MESH:D000077152
25114826	681	691	tacrolimus	Chemical	MESH:D016559
25114826	Cotreatment	MESH:D000077152	MESH:D016559
25114826	Negative_Correlation	MESH:D000077152	MESH:D020258
25114826	Positive_Correlation	MESH:D016559	MESH:D020258
25114826	Positive_Correlation	MESH:D016559	MESH:D012877
25114826	Negative_Correlation	MESH:D000077152	MESH:D012877
25114826	Positive_Correlation	MESH:D016559	MESH:D001523
25114826	Negative_Correlation	MESH:D000077152	MESH:D001523

